ArticleThe oncologist2020

A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer.

Richard Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.